Giuseppe Caff
Soft tissue sarcomas (STS) are rare neoplasms (1% of all cancers in US with a prevalence of 10520 new cases/year) although there are more than 50 different histological type.The current management of STS is addressed to excision of the tumor and to preserve limb function as better as possible; respectingthis balance has been always a challenge for the orthopedic oncology and the importance of treating patients with such sarcomas with wideradical resections obtaining negative pathological margins has beenunderlined in many studies.
இந்தக் கட்டுரையைப் பகிரவும்
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 